This provides up to an additional $11,375 beyond the standard DRG payment for the procedure, according to a news relese. It’s available at facilities that provide inpatient care for spinal stenosis and spondylolisthesis.
The TOPS System earned the FDA’s breakthrough technology designation in 2020 and granted PMA approval in June. The system is an alternative to lumbar spinal fusion for patients with spinal stenosis and spondylolisthesis.
Recent data supported the cost-effectiveness of the system.
